Multi-mode Stroke Rehabilitation System: Development and Validation of Clinical Efficacy

Sponsor
Chang Gung Memorial Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04441190
Collaborator
(none)
32
2
3
11.9
16
1.3

Study Details

Study Description

Brief Summary

The specific study aims will be:
  1. To develop the novel, digital, and interactive MSR system of arm and hand with integrated digital action observation therapy (AOT) and mirror therapy (MT).

  2. To pilot usability testing for examining the feasibility of this new MSR system from the users' experiences and feedback.

  3. To examine the treatment effects of digital AOT, digital MT and a control intervention in patients with stroke by conducting a randomized controlled trial.

  4. To identify who will be the possible good responders to digital AOT and MT based on their baseline motor function and mental imagery abilities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digital Action Observation Therapy (Digital AOT)
  • Behavioral: Digital Mirror Therapy (Digital MT)
  • Behavioral: Conventional Occupational Therapy
N/A

Detailed Description

Phase I: Multi-mode stroke rehabilitation (MSR) System Development & Usability Testing

Ten patients with stroke and 4 certified occupational therapists were recruited in this phase I study. During the pilot testing, each stroke patient will try to use each training mode of digital AOT and MT by the assistance of the therapist. At the end of the pilot testing, the patients and the therapists will be asked to complete the System Usability Scale and a self-designed questionnaire to assess the user experience and perspective about this new MSR system and their view of its suitability for stroke patients.

Phase II: Validation of Clinical Treatment Efficacy

This three-arm, single-blind, randomized controlled trial will investigate the treatment effects among the 3 groups of digital AOT, digital MT, and dose-matched control intervention. An estimated 60 patients with stroke will be recruited to participate in this phase II study. Each participant will receive a total of 15 training sessions (60 minutes per session) for 3 to 4 weeks. Clinical outcome measures will be conducted at baseline, immediately after treatment (the fourth week), and at 1 month follow-up after treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
A Novel, Digital, and Interactive Multi-mode Stroke Rehabilitation System of Arm and Hand: Development and Validation of Clinical Efficacy
Actual Study Start Date :
Aug 3, 2020
Actual Primary Completion Date :
May 11, 2021
Actual Study Completion Date :
Jul 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Digital Action Observation Therapy (Digital AOT)

The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.

Behavioral: Digital Action Observation Therapy (Digital AOT)
The participants will be asked to observe videos and then practice what the participants observed.

Experimental: Digital Mirror Therapy (Digital MT)

The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.

Behavioral: Digital Mirror Therapy (Digital MT)
The participants will observe the real-time self-recorded visual illusion, and move their upper limbs as could as possible.

Active Comparator: Conventional Occupational Therapy

The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.

Behavioral: Conventional Occupational Therapy
The participants will receive upper-limb training without providing videos for observing neither providing them mirror illusions of movements.

Outcome Measures

Primary Outcome Measures

  1. Change scores of Fugl-Meyer Assessment [baseline, 4 weeks, 2 months]

    The upper-limb subsection of Fugl-Meyer Assessment is a measure with sound psychometric properties to evaluate motor impairments.

  2. Change scores of Movement Imagery Questionnaire-Revised, Second Edition [baseline, 4 weeks, 2 months]

    The Movement Imagery Questionnaire-Revised, Second Edition is a 14-item questionnaire with sound reliability and validity to evaluate the ability of motion imagination in patients with stroke.

Secondary Outcome Measures

  1. Change scores of Chedoke Arm and Hand Activity Inventory [baseline, 4 weeks, 2 months]

    The Chedoke Arm and Hand Activity Inventory is a reliable and validated measure to assess the independence of stroke patients to perform activities of daily living with an affected upper limb.

  2. Change scores of Box and Block Test [baseline, 4 weeks, 2 months]

    The Box and Block Test is a tool with sound reliability and validity to evaluate hand dexterity of stroke patients.

  3. Change scores of Revised Nottingham Sensory Assessment [baseline, 4 weeks, 2 months]

    The Revised Nottingham Sensory Assessment is a standardized measure with good reliability to assess sensory function in patients with stroke.

  4. Change scores of Barthel Index [baseline, 4 weeks, 2 months]

    The Barthel Index is a validated tool designed to measure activities reflecting the daily living independence.

  5. Change scores of Motor Activity Log [baseline, 4 weeks, 2 months]

    The Motor Activity Log is a semi-structured interview with good psychometric properties to assess the level of use of affected upper limb in 30 main activities of daily living.

  6. Change scores of the health state of EQ-5D-5L [baseline, 4 weeks, 2 months]

    The questionnaire of EQ-5D-5L contains 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and uses a 5-point Likert scale scored from 1 (no problem) to 5 (unable to/extreme problems); whereas, the numerical description of 5 dimensions represents the health state.

  7. Change scores of the visual analogue scale (VAS) of EQ-5D-5L [baseline, 4 weeks, 2 months]

    The VAS of EQ-5D-5L scores will be scored from 0 to 100, with a higher score indicating better overall current health.

  8. Change of joint angles of OPAL wearable sensors [baseline, 4 weeks, 2 months]

    The OPAL wearable sensors is used to objectively record the movements of an affected upper limb in patients with stroke in real time, such as joint angles. Joint angles of the shoulder, elbow, and wrist will be calculated.

  9. Change of joint velocity of OPAL wearable sensors [baseline, 4 weeks, 2 months]

    The OPAL wearable sensors is used to objectively record the movements of an affected upper limb in patients with stroke in real time, such as joint velocity. The angular velocity of shoulder, elbow, and wrist will be also collected.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Phase I: Multi-mode stroke rehabilitation (MSR) System Development and Usability Testing

For stroke patients

Inclusion Criteria:
  • diagnosed as having a unilateral stroke;

  • aged from 20 to 80 years;

  • a baseline score of the Fugl-Meyer Assessment in a range of 20 to 60;

  • able to follow the instructions and able to provide user feedback verbally;

  • without aphasia and neglect

For therapists

Inclusion Criteria:
  • holding an occupational therapist license

Phase II: Validation of Clinical Treatment Efficacy

Inclusion Criteria:
  • diagnosed as having a unilateral stroke;

  • at least 6 months after stroke onset;

  • aged from 20 to 80 years;

  • a baseline score of FMA in a range of 20 to 60;

  • able to follow the study instructions;

  • capable of participating in therapy and assessment sessions

Exclusion Criteria:
  • global or receptive aphasia,

  • severe neglect,

  • major medical problems or comorbidities that have influenced upper-limb usage or caused severe pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taipei Hospital, Ministry of Health and Welfare New Taipei City Taiwan 24213
2 Taoyuan Chang Gung Memorial Hospital Taoyuan City Taiwan 333

Sponsors and Collaborators

  • Chang Gung Memorial Hospital

Investigators

  • Principal Investigator: Yu-Wei Hsieh, PhD, Department of Occupational Therapy, College of Medicine, Chang Gung University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT04441190
Other Study ID Numbers:
  • 201901885A3
First Posted:
Jun 22, 2020
Last Update Posted:
Nov 26, 2021
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chang Gung Memorial Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 26, 2021